Effect of oral magnesium supplementation on outcomes after open heart surgery

The effect oral magnesium supplementation on outcomes improvement of patients after open heart surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201402026778N4

Enrollment

Registered

2014-04-29

Start date

2013-12-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of magnesium metabolism. hypomagnesemia

Interventions

Intervention 1: The experimental group receiving500 mg of oral magnesium supplementation per day. Intervention 2: Patients in the control group will receive the hospital routine care.

Treatment - Drugs

The experimental group receiving500 mg of oral magnesium supplementation per day.

Patients in the control group will receive the hospital routine care

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with non-emergency cardiac surgery; age greater than 30 and less than 70 years; Not suffering from preoperative atrial fibrillation; Not suffering from Preoperative nausea - vomiting and constipation; Not suffering from renal failure; No history of stroke and transient ischemic attack in the past month. Exclusion Criteria: Re operation for bleeding control; Being pacemaker dependent Postoperatively; The incidence of renal failure during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hypomagnesaemia. Timepoint: Preoperative and postoperative third day. Method of measurement: Serum ionized magnesium.;Postoperative Nausea and vomiting. Timepoint: 5 days, the patient's admission to the intensive care unit after cardiac surgery and internal parts of the heart. Method of measurement: Morrow assessment of nausea and vomiting.;Hyperglycemia. Timepoint: 5 days, the patient's admission to the intensive care unit after cardiac surgery and internal parts of the heart. Method of measurement: Measurement of blood glucose.;Constipation. Timepoint: POST SURGERY 10 days. Method of measurement: According to Rome (III),Defecation of patients is recorded.	—

Measure

Time frame

Hypomagnesaemia. Timepoint: Preoperative and postoperative third day. Method of measurement: Serum ionized magnesium.;Postoperative Nausea and vomiting. Timepoint: 5 days, the patient's admission to the intensive care unit after cardiac surgery and internal parts of the heart. Method of measurement: Morrow assessment of nausea and vomiting.;Hyperglycemia. Timepoint: 5 days, the patient's admission to the intensive care unit after cardiac surgery and internal parts of the heart. Method of measurement: Measurement of blood glucose.;Constipation. Timepoint: POST SURGERY 10 days. Method of measurement: According to Rome (III),Defecation of patients is recorded.

—

Secondary

Measure	Time frame
Post Operation Artrial Fibrilation. Timepoint: from the first to 5th postoperation day. Method of measurement: electrocardiogram and intensive care and internal wards central monitoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Mohamadpour

Baqiyyatallah university of medical sciences

bahar_shahab@yahoo.com+98 912 378 1448

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026